Paul Rennie

Professor

Academic Appointment

Professor

Research Focus

Cancers

Degrees / Designations

B.Sc., PhD

Contact Info

prennie@prostatecentre.com

News and Awards

A novel approach to outsmart prostate cancer

Nov 5, 2018

Technology and expertise align, resulting in novel potential treatment for lethal prostate cancer

Feb 4, 2016

Potential prostate cancer treatment developed in B.C. gets big boost

Dec 15, 2015

People in profile: Miriam Butler

Jan 26, 2015

Local prostate cancer research excellence recognized internationally

Mar 20, 2014

Publications

International journal of cancer -
Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo.
Lee JB, Zhang K, Tam YY, Tam YK, Belliveau NM, Sung VY, Lin PJ, LeBlanc E, Ciufolini MA, Rennie PS, Cullis PR
Journal of medicinal chemistry -
Targeting the binding function 3 (BF3) site of the human androgen receptor through virtual screening.
Lack NA, Axerio-Cilies P, Tavassoli P, Han FQ, Chan KH, Feau C, LeBlanc E, Guns ET, Guy RK, Rennie PS, Cherkasov A
The Prostate -
Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.
Thomas C, Wafa LA, Lamoureux F, Cheng H, Fazli L, Gleave ME, Rennie PS
Journal of medicinal chemistry -
Inhibitors of androgen receptor activation function-2 (AF2) site identified through virtual screening.
Axerio-Cilies P, Lack NA, Nayana MR, Chan KH, Yeung A, Leblanc E, Guns ES, Rennie PS, Cherkasov A
Cancer gene therapy -
Fibroblast growth factor and ornithine decarboxylase 5'UTRs enable preferential expression in human prostate cancer cells and in prostate tumors of PTEN(-/-) transgenic mice.
Moussavi M, Moshgabadi N, Fazli L, Leblanc E, Zhang K, Jia W, Rennie PS

Working in the lab

Are you a researcher?

Update or create your researcher profile on our online directory.

Update Profile Create New Profile